Founded in 2014 as a spin-out company from EPFL, InVivoSwiss is an innovative preclinical optical imaging company with an exclusive patent pending technology based on the combination of activatable probes tailored to key pharmaceutical targets, a novel implantable biosensor technology and a wearable optical imaging device, compatible with all preclinical animal models. The combination of these unique technologies accelerate our clients drug discovery pipelines by facilitating the non-invasive monitoring of biological pathways and targets in live animals. InVivoSwiss offer custom probe design, reporter technology, hardware and expertise for virtually any optical imaging application.
Company Details
- Founded
- 2014
- Address
- Epfl Innovation Park, Bâtiment C, Lausanne,1015,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.invivoswiss.ch/
- Keywords
- In vivo imaging, Bioluminescence, Fluorescence, Luciferin, Caged-luciferin, Intra-operative imaging, Metabolite uptake, Protease activity, Oncology, Infectious Diseases, Non-invasive, Real-time, Small animal models, Drug discovery, Drug development.
- HQ
- Lausanne
Invivoswiss Sa Questions
Invivoswiss Sa's website is http://www.invivoswiss.ch/
Invivoswiss Sa's LinkedIn profile is https://ch.linkedin.com/company/invivoswisssa
Invivoswiss Sa's industry is
Biotechnology Research
Invivoswiss Sa's top competitors are
Optimus Integrated Surgical Environment Ag,
En-Confiance,
Cincap Gmbh,
Ammann Patent Attorneys Ltd.,
Legal Marque,
Edm - Essence De Marque,
Tact Strategy,
Pz Patentzentrum Ag,
Adipse Sàrl,
Cabinet Coendoz.
Invivoswiss Sa's categories are Biotechnology Research
Invivoswiss Sa's founding year is 2014
